0001209191-23-049013.txt : 20230911 0001209191-23-049013.hdr.sgml : 20230911 20230911190501 ACCESSION NUMBER: 0001209191-23-049013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230907 FILED AS OF DATE: 20230911 DATE AS OF CHANGE: 20230911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szalay Aladar CENTRAL INDEX KEY: 0001937513 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41599 FILM NUMBER: 231248732 MAIL ADDRESS: STREET 1: C/O GENELUX CORPORATION STREET 2: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX Corp CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-267-9889 MAIL ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENELUX CORP DATE OF NAME CHANGE: 20030508 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-07 0 0001231457 GENELUX Corp GNLX 0001937513 Szalay Aladar C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 0 0 1 0 0 Common Stock 2023-09-07 4 S 0 9938 24.1212 D 159555 I By Spouse Common Stock 2023-09-07 4 S 0 2508 25.3395 D 157047 I By Spouse Common Stock 2023-09-08 4 S 0 13672 22.7773 D 143375 I By Spouse Common Stock 2023-09-08 4 S 0 8523 23.4857 D 134852 I By Spouse Common Stock 2023-09-08 4 S 0 2636 24.1852 D 132216 I By Spouse Common Stock 32167 D Common Stock 2258760 I By Trust Common Stock 550000 I By Trust Common Stock 1589577 I By Trust The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $23.79 to $24.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The Form 3 filed by the reporting person on January 25, 2023 and the Form 4 filed by the reporting person on January 30, 2023 inadvertently overstated the amount of securities beneficially owned by one share. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $25.03 to $25.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.16 to $23.1561, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $23.16 to $24.155, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $24.165 to $24.205, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Shares held by The Szalay 2009 Irrevocable Trust. Shares held by The Szalay 2010 Children's Trust. Shares held by The Szalay 2010 Retained Annuity Trust. /s/ Aladar Szalay 2023-09-11